Adding Bevacizumab To Initial Glioblastoma Treatment Doesn't Improve Overall Survival
Glioblastoma is the most common primary malignant adult brain tumor and, despite treatment advances in recent years, the average survival of patients enrolled in clinical trials is less than 16…